FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Much More Aggressive FDA Enforcement Seen Coming

[ Price : $8.95]

Speaking in Washington, DC, before FDLIs Enforcement and Litigation Conference, FDA officials cite statistics, recent regulatory a...

Cyber Mischief Slows H1N1 Flu Vaccine Acceptance

[ Price : $8.95]

Cyber mischief about the presence/absence of controversial adjuvants in U.S. licensed H1N1 vaccines slows their public acceptance ...

New Mailing Address for PDUFA Payments

[ Price : $8.95]

FDA anounces an updated mailing address for Prescription Drug User Fee Act (PDUFA) payments that are made by courier delivery (e.g...

Committee Questions Azfibrocel-T Safety

[ Price : $8.95]

FDAs Cellular, Tissue, and Gene Therapies Advisory Committee votes not to recommend to FDA that Fibrocell Sciences azfibrocel-T is...

Senator Wants End to DTC Tax Breaks

[ Price : $8.95]

Sen. Al Franken says he wants to eliminate tax breaks for health products companies that market to consumers and providers.

New Indication for RSB Spine InterPlate C-Ti

[ Price : $8.95]

FDA clears RSB Spines InterPlate C-Ti interbody fusion device as an anterior cervical plate.

Depomed Plans FDA Meeting on Serada

[ Price : $8.95]

Depomed plans to meet with FDA to discuss Phase 3 trial results of its Serada non-hormonal extended release gabapentin for treatin...

More FDA-483s and EIRs, etc., Posted

[ Price : $8.95]

FDA Webview posts to our site further FDA inspection documents we have received from FDA pursuant to our FOI requests. They are fo...

Pfizer Halts Enrollment in Lung Cancer Trial

[ Price : $8.95]

Pfizer stops enrolling patients in a late-stage lung cancer trial involving figitumumab due to safety concerns.